Microbiology FDA 483 (Aurobindo/Eugia Pharma) : No adequate validation of the aseptic process to prevent microbiological contamination
(1) Block *** Line *** re-qualification and *** exposure were not adequately performed:
(a) During *** re-qualification, Chemical Indicators (CI)